BioCentury | Sep 17, 2020
Product Development

Sept. 16 Quick Takes: AAT deficiency data lift Arrowhead; plus Metacrine’s IPO, Seer spinout and PDUFA dates for Niemann-Pick, burn therapies

...Price Associates, Invus, Maverick Ventures, Emerson Collective, Wing VC as well as new investors, including Bruker Corp....
BioCentury | Mar 25, 2020
Product Development

Bruker-Novacyt, PerkinElmer launch COVID-19 diagnostics; plus Nuclein speeds development its PCR test

...the U.S. on Tuesday, while another company is speeding up development of an PCR self-test. Bruker Corp....
...with the GenoXtract automated genome extraction device and associated kits from Bruker subsidiary Bruker-Hain Diagnostics. Bruker...
BioCentury | May 2, 2016
Finance

Private payday

...NYSE:CRL) 5/4 Pre $0.90 $0.79 14% Ligand Pharmaceuticals Inc. (NASDAQ:LGND) 5/4 Pre $0.67 $0.33 103% Bruker Corp....
BioCentury | Apr 11, 2016
Analyst Picks & Changes

Analyst picks & changes

...cut its workforce by 38%. King also removed his $6 target on the BIND-014 data. Bruker Corp....
BioCentury | Feb 8, 2016
Finance

Upsizing Qiming

...NA €1.27 €1.39 -9% Charles River Laboratories International Inc. (NYSE:CRL) 2/10 Pre $0.94 $0.81 16% Bruker Corp....
BioCentury | Nov 23, 2015
Financial News

Bruker financial update

...Bruker said its board authorized a new, $225 million share repurchase program over two years. Bruker...
BioCentury | Aug 3, 2015
Finance

NK-ocking out cancer

...NASDAQ:LGND) 8/4 Post $0.40 $0.24 67% Arena Pharmaceuticals Inc. (NASDAQ:ARNA) 8/5 Post -$0.14 $0.03 NA Bruker Corp....
BioCentury | May 25, 2015
Analyst Picks & Changes

Analyst picks & changes

...I data for the first CFD candidate to treat paroxysmal nocturnal hemoglobinuria (PNH) in 1H16. Bruker Corp....
...Lawson Downgrade Neutral (from buy) -9% $19.60 Lawson downgraded but maintained his $22 target after Bruker...
BioCentury | May 4, 2015
Finance

Build to bye-bye

...Pink:MPSYF) 5/5 NA NA €0.04 NA Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) 5/5 NA $0.22 $0.22 0% Bruker Corp....
BioCentury | Apr 13, 2015
Analyst Picks & Changes

Analyst picks & changes

...& changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/10 cls Bruker Corp....
...the October 2014 exit of Agilent Technologies Inc. (NYSE:A) from the NMR market, Leonard said Bruker...
Items per page:
1 - 10 of 152
BioCentury | Sep 17, 2020
Product Development

Sept. 16 Quick Takes: AAT deficiency data lift Arrowhead; plus Metacrine’s IPO, Seer spinout and PDUFA dates for Niemann-Pick, burn therapies

...Price Associates, Invus, Maverick Ventures, Emerson Collective, Wing VC as well as new investors, including Bruker Corp....
BioCentury | Mar 25, 2020
Product Development

Bruker-Novacyt, PerkinElmer launch COVID-19 diagnostics; plus Nuclein speeds development its PCR test

...the U.S. on Tuesday, while another company is speeding up development of an PCR self-test. Bruker Corp....
...with the GenoXtract automated genome extraction device and associated kits from Bruker subsidiary Bruker-Hain Diagnostics. Bruker...
BioCentury | May 2, 2016
Finance

Private payday

...NYSE:CRL) 5/4 Pre $0.90 $0.79 14% Ligand Pharmaceuticals Inc. (NASDAQ:LGND) 5/4 Pre $0.67 $0.33 103% Bruker Corp....
BioCentury | Apr 11, 2016
Analyst Picks & Changes

Analyst picks & changes

...cut its workforce by 38%. King also removed his $6 target on the BIND-014 data. Bruker Corp....
BioCentury | Feb 8, 2016
Finance

Upsizing Qiming

...NA €1.27 €1.39 -9% Charles River Laboratories International Inc. (NYSE:CRL) 2/10 Pre $0.94 $0.81 16% Bruker Corp....
BioCentury | Nov 23, 2015
Financial News

Bruker financial update

...Bruker said its board authorized a new, $225 million share repurchase program over two years. Bruker...
BioCentury | Aug 3, 2015
Finance

NK-ocking out cancer

...NASDAQ:LGND) 8/4 Post $0.40 $0.24 67% Arena Pharmaceuticals Inc. (NASDAQ:ARNA) 8/5 Post -$0.14 $0.03 NA Bruker Corp....
BioCentury | May 25, 2015
Analyst Picks & Changes

Analyst picks & changes

...I data for the first CFD candidate to treat paroxysmal nocturnal hemoglobinuria (PNH) in 1H16. Bruker Corp....
...Lawson Downgrade Neutral (from buy) -9% $19.60 Lawson downgraded but maintained his $22 target after Bruker...
BioCentury | May 4, 2015
Finance

Build to bye-bye

...Pink:MPSYF) 5/5 NA NA €0.04 NA Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) 5/5 NA $0.22 $0.22 0% Bruker Corp....
BioCentury | Apr 13, 2015
Analyst Picks & Changes

Analyst picks & changes

...& changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/10 cls Bruker Corp....
...the October 2014 exit of Agilent Technologies Inc. (NYSE:A) from the NMR market, Leonard said Bruker...
Items per page:
1 - 10 of 152